1、Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report[ J]. Ocul Surf, 2017, 15(3): 404-437.Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report[ J]. Ocul Surf, 2017, 15(3): 404-437.
2、Levitt AE, Galor A, Small L, et al. Pain sensitivity and autonomic nervous system parameters as predictors of dry eye symptoms after LASIK[ J]. Ocul Surf, 2021, 19: 275-281.Levitt AE, Galor A, Small L, et al. Pain sensitivity and autonomic nervous system parameters as predictors of dry eye symptoms after LASIK[ J]. Ocul Surf, 2021, 19: 275-281.
3、卜凡洁, 张彦青, 解军波. TRPA1离子通道及其功能研究进展[ J].中国现代应用药学, 2021, 38(13): 1618-1626.
BU Fanjie, ZHANG Yanqing, XIE Junbo. Research progress of TRPA 1 ion channel and its function[ J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(13): 1618-1626.卜凡洁, 张彦青, 解军波. TRPA1离子通道及其功能研究进展[ J].中国现代应用药学, 2021, 38(13): 1618-1626.
BU Fanjie, ZHANG Yanqing, XIE Junbo. Research progress of TRPA 1 ion channel and its function[ J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(13): 1618-1626.
4、Yuan JH, Schulman BR, Effraim PR, et al. Genomic analysis of 21 patients with corneal neuralgia after refractive surgery[ J]. Pain Rep,2020, 5(4): e826.Yuan JH, Schulman BR, Effraim PR, et al. Genomic analysis of 21 patients with corneal neuralgia after refractive surgery[ J]. Pain Rep,2020, 5(4): e826.
5、Horváth á, Tékus V, Boros M, et al. Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice[ J]. Arthritis Res Ther, 2016, 18: 6.Horváth á, Tékus V, Boros M, et al. Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice[ J]. Arthritis Res Ther, 2016, 18: 6.
6、Li F, Yang W, Jiang H, et al. TRPV1 activity and substance P release are required for corneal cold nociception[ J]. Nat Commun, 2019,10(1): 5678.Li F, Yang W, Jiang H, et al. TRPV1 activity and substance P release are required for corneal cold nociception[ J]. Nat Commun, 2019,10(1): 5678.
7、Demartini C, Greco R, Zanaboni AM, et al. Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: study in an animal model[ J]. Int J Mol Sci, 2018, 19(11): 3320.Demartini C, Greco R, Zanaboni AM, et al. Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: study in an animal model[ J]. Int J Mol Sci, 2018, 19(11): 3320.
8、Steinhoff MS, von Mentzer B, Geppetti P, et al. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease[ J]. Physiol Rev, 2014, 94(1): 265-301.Steinhoff MS, von Mentzer B, Geppetti P, et al. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease[ J]. Physiol Rev, 2014, 94(1): 265-301.
9、Zieglg?nsberger W. Substance P and pain chronicity[ J]. Cell Tissue Res, 2019, 375(1): 227-241.Zieglg?nsberger W. Substance P and pain chronicity[ J]. Cell Tissue Res, 2019, 375(1): 227-241.
10、 Graefe SB, Mohiuddin SS. Biochemistry, Substance P[M]. Treasure Island (FL): StatPearls Publishing, 2022. Graefe SB, Mohiuddin SS. Biochemistry, Substance P[M]. Treasure Island (FL): StatPearls Publishing, 2022.
11、Bignami F, Rama P, Ferrari G. Substance P and its inhibition in ocular inflammation[ J]. Curr Drug Targets, 2016, 17(11): 1265-1274.Bignami F, Rama P, Ferrari G. Substance P and its inhibition in ocular inflammation[ J]. Curr Drug Targets, 2016, 17(11): 1265-1274.
12、Liu L, Yudin Y, Rohacs T. Diacylglycerol kinases regulate TRPV1 channel activity[ J]. J Biol Chem, 2020, 295(24): 8174-8185.Liu L, Yudin Y, Rohacs T. Diacylglycerol kinases regulate TRPV1 channel activity[ J]. J Biol Chem, 2020, 295(24): 8174-8185.
13、Rocco ML, Soligo M, Manni L, et al. Nerve growth factor: early studies and recent clinical trials[ J]. Curr Neuropharmacol, 2018, 16(10):1455-1465.Rocco ML, Soligo M, Manni L, et al. Nerve growth factor: early studies and recent clinical trials[ J]. Curr Neuropharmacol, 2018, 16(10):1455-1465.
14、Barker PA, Mantyh P, Arendt-Nielsen L, et al. Nerve growth factor signaling and its contribution to pain[ J]. J Pain Res, 2020, 13:1223-1241.Barker PA, Mantyh P, Arendt-Nielsen L, et al. Nerve growth factor signaling and its contribution to pain[ J]. J Pain Res, 2020, 13:1223-1241.
15、Chang CH, Chang YS, Hsieh YL. Transient receptor potential vanilloid subtype 1 depletion mediates mechanical allodynia through cellular signal alterations in small-fiber neuropathy[ J]. Pain Rep,2021, 6(1): e922.Chang CH, Chang YS, Hsieh YL. Transient receptor potential vanilloid subtype 1 depletion mediates mechanical allodynia through cellular signal alterations in small-fiber neuropathy[ J]. Pain Rep,2021, 6(1): e922.
16、Diogenes A, Akopian AN, Hargreaves KM. NGF up-regulates TRPA1:
implications for orofacial pain[ J]. J Dent Res, 2007, 86(6): 550-555.Diogenes A, Akopian AN, Hargreaves KM. NGF up-regulates TRPA1:
implications for orofacial pain[ J]. J Dent Res, 2007, 86(6): 550-555.
17、Patil MJ, Salas M, Bialuhin S, et al. Sensitization of small-diameter sensory neurons is controlled by TRPV1 and TRPA1 association[ J]. FASEB J, 2020, 34(1): 287-302.Patil MJ, Salas M, Bialuhin S, et al. Sensitization of small-diameter sensory neurons is controlled by TRPV1 and TRPA1 association[ J]. FASEB J, 2020, 34(1): 287-302.
18、Lee A, Blair HA. Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation[ J]. Drugs, 2020,80(11): 1101-1108.Lee A, Blair HA. Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation[ J]. Drugs, 2020,80(11): 1101-1108.
19、Schneider AH, Machado CC, Veras FP, et al. Neutrophil extracellular traps mediate joint hyperalgesia induced by immune inflammation[ J].Rheumatology (Oxford), 2021, 60(7): 3461-3473.Schneider AH, Machado CC, Veras FP, et al. Neutrophil extracellular traps mediate joint hyperalgesia induced by immune inflammation[ J].Rheumatology (Oxford), 2021, 60(7): 3461-3473.
20、 Kodji X, Kee Z, McKenna R, et al. Evidence that a TRPA1-mediated murine model of temporomandibular joint pain involves NLRP3 inflammasome activation[ J]. Pharmaceuticals (Basel), 2021,14(11): 1073. Kodji X, Kee Z, McKenna R, et al. Evidence that a TRPA1-mediated murine model of temporomandibular joint pain involves NLRP3 inflammasome activation[ J]. Pharmaceuticals (Basel), 2021,14(11): 1073.
21、Yi MH, Liu YU, Umpierre AD, et al. Optogenetic activation of spinal microglia triggers chronic pain in mice[ J]. PLoS Biol, 2021, 19(3): e3001154.Yi MH, Liu YU, Umpierre AD, et al. Optogenetic activation of spinal microglia triggers chronic pain in mice[ J]. PLoS Biol, 2021, 19(3): e3001154.
22、Kanno K, Shimizu K, Shinoda M, et al. Role of macrophage-mediated Toll-like receptor 4-interleukin-1R signaling in ectopic tongue pain associated with tooth pulp inflammation[ J]. J Neuroinflammation,2020, 17(1): 312.Kanno K, Shimizu K, Shinoda M, et al. Role of macrophage-mediated Toll-like receptor 4-interleukin-1R signaling in ectopic tongue pain associated with tooth pulp inflammation[ J]. J Neuroinflammation,2020, 17(1): 312.
23、李秋月, 许海玉, 杨洪军. 促炎因子TNF-α, IL-1β, IL-6在神经病理性疼痛中的研究进展[ J]. 中国中药杂志, 2017, 42(19):3709-3712.
LI Qiuyue, XU Haiyu, YANG Hongjun. Research progress of pro- inflammatory factors TNF-α, IL-1β, IL-6 in neuropathic pain[ J]. China Journal of Chinese Materia Medica, 2017, 42(19): 3709-3712.李秋月, 许海玉, 杨洪军. 促炎因子TNF-α, IL-1β, IL-6在神经病理性疼痛中的研究进展[ J]. 中国中药杂志, 2017, 42(19):3709-3712.
LI Qiuyue, XU Haiyu, YANG Hongjun. Research progress of pro- inflammatory factors TNF-α, IL-1β, IL-6 in neuropathic pain[ J]. China Journal of Chinese Materia Medica, 2017, 42(19): 3709-3712.
24、Noh MC, Stemkowski PL, Smith PA. Long-term actions of interleukin-
1β on K+, Na+ and Ca2+ channel currents in small, IB4-positive dorsal
root ganglion neurons; possible relevance to the etiology of neuropathic
pain[ J]. J Neuroimmunol, 2019, 332: 198-211.Noh MC, Stemkowski PL, Smith PA. Long-term actions of interleukin-
1β on K+, Na+ and Ca2+ channel currents in small, IB4-positive dorsal
root ganglion neurons; possible relevance to the etiology of neuropathic
pain[ J]. J Neuroimmunol, 2019, 332: 198-211.
25、Chen H, Gan X, Li Y, et al. NLRP12- and NLRC4-mediated corneal
epithelial pyroptosis is driven by GSDMD cleavage accompanied by
IL-33 processing in dry eye[ J]. Ocul Surf, 2020, 18(4): 783-794.Chen H, Gan X, Li Y, et al. NLRP12- and NLRC4-mediated corneal
epithelial pyroptosis is driven by GSDMD cleavage accompanied by
IL-33 processing in dry eye[ J]. Ocul Surf, 2020, 18(4): 783-794.
26、 Mercadante S, Arcuri E, Santoni A. Opioid-Induced Tolerance and Hyperalgesia[ J]. CNS Drugs, 2019, 33(10): 943-955. Mercadante S, Arcuri E, Santoni A. Opioid-Induced Tolerance and Hyperalgesia[ J]. CNS Drugs, 2019, 33(10): 943-955.
27、Schmidt S, Bethge C, F?rster MH, et al. Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain[ J]. Clin J Pain, 2007, 23(7): 605-611.Schmidt S, Bethge C, F?rster MH, et al. Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain[ J]. Clin J Pain, 2007, 23(7): 605-611.
28、聂登云, 吕志刚. 调节阿片受体MOR胞内信号转导的分子机制研究进展[ J]. 中国疼痛医学杂志, 2019, 25(10): 725-731.
NIE Dengyun, Lü Zhigang. Research progress in the molecular mechanism regulating the intracellular signal transduction of the opioid receptor MOR[ J]. Chinese Journal of Pain Medicine, 2019, 25(10):725-731.聂登云, 吕志刚. 调节阿片受体MOR胞内信号转导的分子机制研究进展[ J]. 中国疼痛医学杂志, 2019, 25(10): 725-731.
NIE Dengyun, Lü Zhigang. Research progress in the molecular mechanism regulating the intracellular signal transduction of the opioid receptor MOR[ J]. Chinese Journal of Pain Medicine, 2019, 25(10):725-731.
29、Scherer PC, Zaccor NW, Neumann NM, et al. TRPV1 is a physiological regulator of μ-opioid receptors[ J]. Proc Natl Acad Sci U S A, 2017,114(51): 13561-13566.Scherer PC, Zaccor NW, Neumann NM, et al. TRPV1 is a physiological regulator of μ-opioid receptors[ J]. Proc Natl Acad Sci U S A, 2017,114(51): 13561-13566.
30、 Meotti FC, Figueiredo CP, Manjavachi M, et al. The transient receptor potential ankyrin-1 mediates mechanical hyperalgesia induced by the activation of B1 receptor in mice[ J]. Biochem Pharmacol, 2017, 125:75-83. Meotti FC, Figueiredo CP, Manjavachi M, et al. The transient receptor potential ankyrin-1 mediates mechanical hyperalgesia induced by the activation of B1 receptor in mice[ J]. Biochem Pharmacol, 2017, 125:75-83.
31、Grabauskas G, Wu X, Gao J, et al. Prostaglandin E2, produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice[ J]. Gastroenterology,2020, 158(8): 2195-2207.e6.Grabauskas G, Wu X, Gao J, et al. Prostaglandin E2, produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice[ J]. Gastroenterology,2020, 158(8): 2195-2207.e6.
32、Guilarte M, Vicario M, Martínez C, et al. Peripheral corticotropin-releasing factor triggers jejunal mast cell activation and abdominal pain in patients with diarrhea-predominant irritable bowel syndrome[ J].Am J Gastroenterol, 2020, 115(12): 2047-2059.Guilarte M, Vicario M, Martínez C, et al. Peripheral corticotropin-releasing factor triggers jejunal mast cell activation and abdominal pain in patients with diarrhea-predominant irritable bowel syndrome[ J].Am J Gastroenterol, 2020, 115(12): 2047-2059.
33、Cho W, Mittal SK, Elbasiony E, et al. Spatial distribution of mast cells
regulates asymmetrical angiogenesis at the ocular surface[ J]. Am J
Pathol, 2021, 191(6): 1108-1117.Cho W, Mittal SK, Elbasiony E, et al. Spatial distribution of mast cells
regulates asymmetrical angiogenesis at the ocular surface[ J]. Am J
Pathol, 2021, 191(6): 1108-1117.
34、Bielory L. Allergic inflammation of the anterior surface of the eye[ J].Allergy Asthma Proc, 2020, 41(6): 449-453.Bielory L. Allergic inflammation of the anterior surface of the eye[ J].Allergy Asthma Proc, 2020, 41(6): 449-453.
35、Tsagareli MG, Nozadze I, Tsiklauri N, et al. Thermal hyperalgesia and
mechanical allodynia elicited by histamine and non-histaminergic
itch mediators: respective involvement of TRPV1 and TRPA1[ J].
Neuroscience, 2020, 449: 35-45.Tsagareli MG, Nozadze I, Tsiklauri N, et al. Thermal hyperalgesia and
mechanical allodynia elicited by histamine and non-histaminergic
itch mediators: respective involvement of TRPV1 and TRPA1[ J].
Neuroscience, 2020, 449: 35-45.
36、Lansu K, Karpiak J, Liu J, et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2[ J]. Nat Chem Biol, 2017, 13(5):529-536.Lansu K, Karpiak J, Liu J, et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2[ J]. Nat Chem Biol, 2017, 13(5):529-536.
37、Kido K, Katagiri N, Kawana H, et al. Nociceptive sensitization by activation of protease-activated receptor 2 in a rat model of incisional pain[ J]. Brain Sci, 2021, 11(2): 144.Kido K, Katagiri N, Kawana H, et al. Nociceptive sensitization by activation of protease-activated receptor 2 in a rat model of incisional pain[ J]. Brain Sci, 2021, 11(2): 144.
38、Mrozkova P, Palecek J, Spicarova D. The role of protease-activated receptor type 2 in nociceptive signaling and pain[ J]. Physiol Res, 2016,65(3): 357-367.Mrozkova P, Palecek J, Spicarova D. The role of protease-activated receptor type 2 in nociceptive signaling and pain[ J]. Physiol Res, 2016,65(3): 357-367.
39、Kopruszinski CM, Thornton P, Arnold J, et al. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine[ J]. Cephalalgia, 2020, 40(14): 1535-1550.Kopruszinski CM, Thornton P, Arnold J, et al. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine[ J]. Cephalalgia, 2020, 40(14): 1535-1550.
40、Neubert JK, Mannes AJ, Karai LJ, et al. Perineural resiniferatoxin
selectively inhibits inflammatory hyperalgesia[ J]. Mol Pain, 2008, 4: 3.Neubert JK, Mannes AJ, Karai LJ, et al. Perineural resiniferatoxin
selectively inhibits inflammatory hyperalgesia[ J]. Mol Pain, 2008, 4: 3.
41、Surowy CS, Neelands TR, Bianchi BR, et al. (R)-(5-tert-butyl-2,3-
dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks
polymodal activation of transient receptor potential vanilloid 1
receptors in vitro and heat-evoked firing of spinal dorsal horn neurons
in vivo[ J]. J Pharmacol Exp Ther, 2008, 326(3): 879-888.Surowy CS, Neelands TR, Bianchi BR, et al. (R)-(5-tert-butyl-2,3-
dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks
polymodal activation of transient receptor potential vanilloid 1
receptors in vitro and heat-evoked firing of spinal dorsal horn neurons
in vivo[ J]. J Pharmacol Exp Ther, 2008, 326(3): 879-888.
